Malondialdehyde and sulfhydryl groups as biomarkers of oxidative stress in patients with systemic lupus erythematosus

Revista Brasileira de Reumatologia

Volumn 52, Issue 4, 2012, Pages 658-660

  Pérez, Yenly G ^a   Pérez, Lissett Caridad González ^a   Rita de Cassia M Netto ^b   de Lima, Domingos S N ^c   Lima, Emerson S ^a  

^a FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^c Hospital Universitario Getúlio Vargas   (Brazil)

Author keywords

Antioxidants; Lupus erythematosus systemic; Oxidative stress; Uric acid

Indexed keywords

MALONALDEHYDE; THIOL GROUP; URIC ACID;

ADULT; ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OXIDATIVE STRESS; SCHOOL CHILD; SPECTROPHOTOMETRY; SYSTEMIC LUPUS ERYTHEMATOSUS; URIC ACID BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; SULFHYDRYL COMPOUNDS;

EID: 84866513622     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0482-50042012000400016     Document Type: Article

References (25)

1. Karanam SA, Dharmavarapu PK, D Souza R, Upadhya S, Kumar V, Kedage V et al. Lúpus eritematoso sistêmico. In: Goldman L, Ausiello, Cecil D (eds.). Tratado de medicina interna. 22.ed. Rio de Janeiro: Elsevier; 2005, p.1937-47.
2. Kumar V, Abbas AK, Fausto N. Adaptação, dano e morte celular. In: Kumar V, Abbas AK, Fausto N, Robbins & Cotran (eds.). Bases patológicas das doenças. 7.ed. Rio de Janeiro: Elsevier; 2005, p.17-9.
3. Nery FG, Borba EF, Neto FL. Influence of the psychosocial stress on systemic lupus erythematosus. Rev Bras Reumatol 2004; 44(5):355-61.
4. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160(1):1-40.
5. Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzani R. Atherosclerosis and oxidative stress. Histol Histopathol 2008; 23(3):381-90.
6. Zawia NH, Lahiri DK, Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med 2009; 46(9):1241-9.
7. Chang YC, Chuang, LM. The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. Am J Transl Res 2010; 2(3):316-31.
8. Filippin LI, Vercelino R, Marroni NP, Xavier RM. Redox influence on the inflammatory response in rheumatoid arthritis. Rev Bras Reumatol 2008; 48(1):17-24.
9. Amara A, Constans J, Chaugier C, Sebban A, Dobourg L, Peuchant E et al. Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides. Clin Exp Immunol 1995; 101:233-8.
10. Kolagal V, Karanam SA, Dharmavarapu PK, D'souza R, Upadhya S, Kumar V et al. Determination of oxidative stress markers and their importance in early diagnosis of uremia-related complications. Indian J Nephrology 2009; 19(1):8-12.
11. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des 2005; 11(32):4145-51.
12. Surita FGC, Cecatti JG, Barini R, Parpinelli MA, Silva JLC. Lúpus e gravidez. Rev Bras de Ginec e Obstetrícia 1997; 19(6):413-7.
13. Morgan PE, Sturgess AD, Davies MJ. Increased levels of serum protein oxidation and correlation with disease activity in SLE. Arthritis Rheum 2005; 52(7):2069-79.
14. Fukunaga K, Takama K, Suzuki T. High performance liquid chomatography determination of plasma malondialdehyde level without a solvent extraction procedure. Anal Biochem 1995; 230(1):20-3.
15. Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 1993; 121(2):197-8.
16. Ferguson JD. Stress that causes palpitations: oxidative stress and atrial fibrillation. Heart Rhythm 2009; 6(7):941-2.
17. Waszczykowska E, Robak E, Wozniacka A, Narbutt J, Torzecka JD, Sysa-Jedrzejowska A. Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation. Mediators of Inflammation 1999; 8(2):93-100.
18. Tewthanom K, Janwityanuchit S, Totemchockchyakarn K, Panomvana D. Correlation of lipid peroxidation and glutathione levels with severity of systemic lupus erythematosus: a pilot study from single center. J Pharm Pharm Sci 2008; 11:30-4.
19. Turgay M, Durak I, Erten S, Ertugrul E, Devrim E, Avci A et al. Oxidative stress and antioxidant parameters in a Turkish group of patients with active and inactive systemic lupus erythematosus. APLAR J Rheumatol 2007; 10:101-6.
20. Wang G, Pierangeli SS, Papalardo E, Ansari GA, Khan MF. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum 2010; 62(7):2064-72.
21. Shah D, Kiran R, Wanchu A, Bhatnagar A. Oxidative stress in systemic lupus erythematosus: Relationship to Th1 cytokine and disease activity. Immunol Letters 2010; 129:7-12.
22. Deminice R, Sicchieri T, Mialich MS, Milani F, Ovidio PP, Jordan AA. Oxidative stress biomarker response to an acute session of hypertrophy-resistance traditional interval training and circuit training. J Strenght Cond Res 2011; 25(3):798-804.
23. Ikeda K, Kawabe K, Iwasaki Y. Do serum acid reflect oxidative stress in the progression of ALS? J Neurol Sci 2009; 287(1-2):294.
24. Morgan PE, Sturgess AD, Davies MJ. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res 2009; 43:117-27.
25. Zhang Q, Ye DQ, Chen GP, Zheng Y. Oxidative protein damage and antioxidant status in systemic lupus. Eryth Clin Exp Dermatol 2009; 35:287-94.